Brawn Biotech Ltd.

View in App
19.42 +0.92 ▲5.0%

01 December 2023, 04:01:00 PM
Volume: 1,222

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.brawnbiotech.com
Market Cap 5.83 Cr.
Enterprise Value(EV) 5.83 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -4.13 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.75 Trailing Twelve Months Ending 2023-09
Book Value / Share 19.03 Trailing Twelve Months Ending 2023-09
Price to Book Value 1.02 Calculated using Price: 19.42
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.30 Cr. 3,000,300 Shares
FaceValue 10
About Brawn Biotech Ltd.
Brawn Pharmaceuticals was incorporated in the year 1985 it operates in health care sector in India and outside India. It has started its business by selling pharmaceutical formulations manufactured by other company's loan license basis. The company is located in New Delhi, India.

Brawn Biotech Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Brawn Biotech Ltd. Performance

View details >>
1 Day
+4.97%
1 Week
+7.59%
1 Month
+19.14%
3 Month
-18.81%
6 Month
+18.49%
1 Year
+6.70%
2 Year
+0.10%
5 Year
-53.49%
10 Year
+231.40%

Brawn Biotech Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 5.91 18.15 22.39 17.62 16.37 6.60 -6.10 -20.53 -12.83
Return on Capital Employed (%) 11.98 26.39 29.04 27.75 23.03 9.74 -3.57 -25.66 -5.94
Return on Assets (%) 2.05 6.80 9.01 6.49 5.93 2.77 -3.24 -12.23 -6.31

Brawn Biotech Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 5 6 7 8 9 9 9 7 6 6
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Curr. Liab. 9 8 10 15 14 11 5 6 8 5
Minority Int.
Equity & Liab. 14 14 17 22 22 20 14 13 14 12
Non Curr. Assets 3 3 0 1 1 1 1 1 1 0
Curr. Assets 11 11 17 22 22 19 13 12 13 11
Misc. Exp. not W/O
Total Assets 14 14 17 22 22 20 14 13 14 12

Brawn Biotech Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 39 47 61 56 65 50 35 9 22 21
Other Income 0 0 1 0 1 0 0 0 0
Total Income 39 47 61 56 66 50 35 9 22 21
Total Expenditure -38 -45 -59 -54 -64 -49 -36 -11 -23 -22
PBIDT 1 1 2 2 2 1 0 -2 0 -1
Interest 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 -1 0 0 0 0 0 0
Exceptional Items
PAT 0 1 1 1 1 1 -1 -2 -1 -1
Adjusted EPS 1 3 5 4 4 2 -2 -5 -3 -4

Brawn Biotech Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 1 -2 0 0 0 0 0
Cash Fr. Inv. 0 0 0 1 0 0 0
Cash Fr. Finan. 0 0 0 0 0 0 0 0 0
Net Change 0 0 0 2 -2 0 0 0 0
Cash & Cash Eqvt 0 0 0 2 0 1 0 0 0 0

Brawn Biotech Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 53.71 53.71 53.71 53.73 53.73 53.72 53.72 53.72 53.72
Public 46.29 46.29 46.29 46.27 46.27 46.28 46.28 46.28 46.28
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Brawn Biotech Ltd. Announcements

View details >>
Thu, 16 Nov 2023
Non Applicability For Filing Of Related Party Disclosures
The confirmation for filing of non applicability of related party transactions for the quarter/half year ended 30/09/2023.
Sat, 11 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
NEWSPAPER PUBLICATION OF RESULTS FOR THE QUARTER /HALF YEAR ENDED 30TH SEPTEMBER 2023.
Fri, 10 Nov 2023
Board Meeting Outcome for Outcome Of The Board Meeting
The Board of the Company at its meeting held today 10th November 2023 has considered and approved the Un-audited Financial Results for the quarter and half year ended on September 30 2023. A copy of the said results along with Limited Review Reports issued by the Auditor is enclosed herewith. The aforesaid Board Meeting Commenced at 01:00 P.M. (IST) and concluded at 01:30 P.M. (IST).

Brawn Biotech Ltd. Technical Scans

View details >>
Fri, 01 Dec 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at High Opening at High
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
Opening at Low for 2 Days Opening at Low for 2 Days

Brawn Biotech Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 295,418.12 1,231.25 +0.4%
Divi's Laboratories Ltd. 100,674.98 3,792.70 +0.1%
Cipla Ltd. 97,418.94 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. 95,866.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. 80,322.42 5,570.00 +0.7%
Mankind Pharma Ltd. 76,800.82 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. 72,809.77 2,151.30 +1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.56 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 75.59 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 28.21 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.83 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 115.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 59.91 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 54.58 2,151.30 +1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.94 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.94 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 3.92 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.36 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.11 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.86 2,151.30 +1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,151.30 +1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,151.30 +1.1%

Brawn Biotech Ltd. FAQ's

What is Brawn Biotech share price?
Can I buy Brawn Biotech shares now?
What is the Market Cap of Brawn Biotech?
What are the key metrics to analyse Brawn Biotech?
What is the 52 Week High and Low of Brawn Biotech?
What is the trend of Brawn Biotech share price?